Suppr超能文献

食管对胃食管反流的表型反应的多样性:免疫决定因素。

Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

作者信息

Fitzgerald R C, Onwuegbusi B A, Bajaj-Elliott M, Saeed I T, Burnham W R, Farthing M J G

机构信息

Cancer Cell Unit, Hutchison-MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.

出版信息

Gut. 2002 Apr;50(4):451-9. doi: 10.1136/gut.50.4.451.

Abstract

BACKGROUND AND AIMS

Approximately 10% of adults experience gastro-oesophageal reflux symptoms with a variable oesophageal response. A total of 60% have no endoscopic abnormality, 30% have oesophagitis, and 10% have Barrett's oesophagus. We investigated whether the inflammatory cell infiltrate and cytokine profiles of these clinical phenotypes merely vary in severity or are fundamentally different.

METHODS

Patients with reflux symptoms and a normal oesophagus (n=18), oesophagitis (n=26), and Barrett's oesophagus (n=22 newly diagnosed, n=28 surveillance) were recruited. Endoscopic and histopathological degrees of inflammation were scored. Cytokine expression was determined by competitive reverse transcriptase-polymerase chain reaction and immunohistochemistry.

RESULTS

In oesophagitis, endoscopic and histopathological grades of inflammation correlated highly. mRNA expression of proinflammatory interleukin (IL)-1beta, IL-8, and interferon gamma (IFN-gamma) were increased 3-10-fold compared with non-inflamed squamous or Barrett's oesophageal samples. There was a modest increase in anti-inflammatory IL-10 but no increase in IL-4. In Barrett's oesophagus, 29/50 had no endoscopic evidence of inflammation and histopathological inflammation was mild in 17/50 and moderate in 24/50, independent of acid suppressants. Expression of IL-1beta, IL-8, and IFN-gamma was similar to non-inflamed squamous mucosa. IL-10 was increased 1.6-fold similar to oesophagitis. IL-4 was increased fourfold, with 100-fold increase in IL-4/T cell receptor expression, compared with squamous oesophagus or oesophagitis.

CONCLUSIONS

Barrett's oesophagus is characterised by a distinct Th-2 predominant cytokine profile compared with the proinflammatory nature of oesophagitis. The specific oesophageal immune responses may influence disease development and progression.

摘要

背景与目的

约10%的成年人有胃食管反流症状,食管反应各不相同。其中60%内镜检查无异常,30%有食管炎,10%有巴雷特食管。我们研究了这些临床表型的炎症细胞浸润和细胞因子谱是仅在严重程度上有所不同,还是存在根本差异。

方法

招募有反流症状且食管正常的患者(n = 18)、食管炎患者(n = 26)以及巴雷特食管患者(新诊断患者n = 22,监测患者n = 28)。对炎症的内镜和组织病理学程度进行评分。通过竞争性逆转录聚合酶链反应和免疫组织化学测定细胞因子表达。

结果

在食管炎中,内镜和组织病理学炎症分级高度相关。与未发炎的鳞状或巴雷特食管样本相比,促炎白细胞介素(IL)-1β、IL-8和干扰素γ(IFN-γ)的mRNA表达增加了3至10倍。抗炎性IL-10有适度增加,但IL-4没有增加。在巴雷特食管中,50例中有29例内镜检查无炎症迹象,50例中有17例组织病理学炎症为轻度,24例为中度,与抑酸剂无关。IL-1β、IL-8和IFN-γ的表达与未发炎的鳞状黏膜相似。IL-10增加了1.6倍,与食管炎相似。与鳞状食管或食管炎相比,IL-4增加了四倍,IL-4/ T细胞受体表达增加了100倍。

结论

与食管炎的促炎性质相比,巴雷特食管的特征是具有明显的以Th-2为主的细胞因子谱。特定的食管免疫反应可能影响疾病的发生和发展。

相似文献

2
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x.
4
8
Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Scand J Gastroenterol. 2010 Dec;45(12):1397-403. doi: 10.3109/00365521.2010.503968. Epub 2010 Jul 14.
9

引用本文的文献

3
The role of IL-33/ST2 axis in esophageal inflammatory diseases and cancers: implications for the immunopathogenesis and immunotherapeutic target?
Therap Adv Gastroenterol. 2025 Jun 12;18:17562848251344049. doi: 10.1177/17562848251344049. eCollection 2025.
4
Gut microbiota, inflammatory cytokines and gastro-esophageal reflux disease: A Mendelian randomization analysis.
Medicine (Baltimore). 2025 Jan 31;104(5):e41386. doi: 10.1097/MD.0000000000041386.
5
A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome.
Gut Microbes. 2024 Jan-Dec;16(1):2413367. doi: 10.1080/19490976.2024.2413367. Epub 2024 Oct 31.
6
Increased PXR and Suppressed T-Cell Signaling Are Associated With Malignant Degeneration of Barrett's Esophagus.
Gastro Hep Adv. 2022 Aug 24;2(1):63-71. doi: 10.1016/j.gastha.2022.08.005. eCollection 2023.
7
Inflammatory responses in esophageal mucosa before and after laparoscopic antireflux surgery.
World J Gastrointest Surg. 2024 Mar 27;16(3):871-881. doi: 10.4240/wjgs.v16.i3.871.
8
Chemoprevention of esophageal adenocarcinoma in a rat surgical model by a cysteinyl leukotriene receptor‑1 antagonist.
Oncol Lett. 2024 Feb 8;27(4):147. doi: 10.3892/ol.2024.14280. eCollection 2024 Apr.
9
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
10
Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia.
Cancer Discov. 2023 Jun 2;13(6):1346-1363. doi: 10.1158/2159-8290.CD-22-0824.

本文引用的文献

2
Interleukin-1 polymorphisms associated with increased risk of gastric cancer.
Nature. 2000 Mar 23;404(6776):398-402. doi: 10.1038/35006081.
3
Stem cells in epithelial tissues.
Science. 2000 Feb 25;287(5457):1431-3. doi: 10.1126/science.287.5457.1431.
4
Health-related quality of life in primary care patients with gastroesophageal reflux disease.
Ann Pharmacother. 1999 Oct;33(10):1032-6. doi: 10.1345/aph.18424.
5
Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.
Am J Gastroenterol. 1999 Sep;94(9):2441-6. doi: 10.1111/j.1572-0241.1999.01372.x.
7
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
N Engl J Med. 1999 Mar 18;340(11):825-31. doi: 10.1056/NEJM199903183401101.
9
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
J Gastrointest Surg. 1998 Jul-Aug;2(4):333-41. doi: 10.1016/s1091-255x(98)80072-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验